Beuschlein F - Search Results

1

Screening for Primary Aldosteronism by Mass Spectrometry Versus Immunoassay Measurements of Aldosterone: A Prospective Within-Patient Study.

Fuld S, Constantinescu G, Pamporaki C, Peitzsch M, Schulze M, Yang J, Müller L, Prejbisz A, Januszewicz A, Remde H, Kürzinger L, Dischinger U, Ernst M, Gruber S, Reincke M, Beuschlein F, Lenders JWM, Eisenhofer G. Fuld S, et al. Among authors: beuschlein f. J Appl Lab Med. 2024 Jul 1;9(4):752-766. doi: 10.1093/jalm/jfae017. J Appl Lab Med. 2024. PMID: 38532521

2

Expression of adrenocorticotrophic hormone receptor mRNA in human adrenocortical neoplasms: correlation with P450scc expression.

Reincke M, Beuschlein F, Latronico AC, Arlt W, Chrousos GP, Allolio B. Reincke M, et al. Among authors: beuschlein f. Clin Endocrinol (Oxf). 1997 May;46(5):619-26. doi: 10.1046/j.1365-2265.1997.1991009.x. Clin Endocrinol (Oxf). 1997. PMID: 9231058

3

Multiple endocrine neoplasia type 1 gene expression is normal in sporadic adrenocortical tumors.

Zwermann O, Beuschlein F, Mora P, Weber G, Allolio B, Reincke M. Zwermann O, et al. Among authors: beuschlein f. Eur J Endocrinol. 2000 Jun;142(6):689-95. doi: 10.1530/eje.0.1420689. Eur J Endocrinol. 2000. PMID: 10822234

4

Molecular adrenocortical tumourigenesis.

Reincke M, Beuschlein F, Slawik M, Borm K. Reincke M, et al. Among authors: beuschlein f. Eur J Clin Invest. 2000 Dec;30 Suppl 3:63-8. doi: 10.1046/j.1365-2362.2000.0300s3063.x. Eur J Clin Invest. 2000. PMID: 11281372 Review.

5

Angiotensin II type 1 receptor and ACTH receptor expression in human adrenocortical neoplasms.

Schubert B, Fassnacht M, Beuschlein F, Zenkert S, Allolio B, Reincke M. Schubert B, et al. Among authors: beuschlein f. Clin Endocrinol (Oxf). 2001 May;54(5):627-32. doi: 10.1046/j.1365-2265.2001.01253.x. Clin Endocrinol (Oxf). 2001. PMID: 11380493

6

Steroidogenic acute regulatory (StAR)-directed immunotherapy protects against tumor growth of StAR-expressing Sp2-0 cells in a rodent adrenocortical carcinoma model.

Ortmann D, Hausmann J, Beuschlein F, Schmenger K, Stahl M, Geissler M, Reincke M. Ortmann D, et al. Among authors: beuschlein f. Endocrinology. 2004 Apr;145(4):1760-6. doi: 10.1210/en.2003-0983. Epub 2004 Jan 8. Endocrinology. 2004. PMID: 14715709

7

Diagnosis of primary aldosteronism: value of different screening parameters and influence of antihypertensive medication.

Seiler L, Rump LC, Schulte-Mönting J, Slawik M, Borm K, Pavenstädt H, Beuschlein F, Reincke M. Seiler L, et al. Among authors: beuschlein f. Eur J Endocrinol. 2004 Mar;150(3):329-37. doi: 10.1530/eje.0.1500329. Eur J Endocrinol. 2004. PMID: 15012618

8

Clinical and molecular evidence for DAX-1 inhibition of steroidogenic factor-1-dependent ACTH receptor gene expression.

Zwermann O, Beuschlein F, Lalli E, Klink A, Sassone-Corsi P, Reincke M. Zwermann O, et al. Among authors: beuschlein f. Eur J Endocrinol. 2005 May;152(5):769-76. doi: 10.1530/eje.1.01908. Eur J Endocrinol. 2005. PMID: 15879363

9

Peroxisome proliferator-activated receptor-gamma agonists suppress adrenocortical tumor cell proliferation and induce differentiation.

Betz MJ, Shapiro I, Fassnacht M, Hahner S, Reincke M, Beuschlein F; German and Austrian Adrenal Network. Betz MJ, et al. Among authors: beuschlein f. J Clin Endocrinol Metab. 2005 Jul;90(7):3886-96. doi: 10.1210/jc.2004-1267. Epub 2005 May 10. J Clin Endocrinol Metab. 2005. PMID: 15886257

10

ACTH 1-24 inhibits proliferation of adrenocortical tumors in vivo.

Zwermann O, Schulte DM, Reincke M, Beuschlein F. Zwermann O, et al. Among authors: beuschlein f. Eur J Endocrinol. 2005 Sep;153(3):435-44. doi: 10.1530/eje.1.01983. Eur J Endocrinol. 2005. PMID: 16131607

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

513 results

Search Page

Filters